CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Baltimore, Maryland, United States and 8 other locations
radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...
Phase 2
Baltimore, Maryland, United States and 5 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Baltimore, Maryland, United States and 19 other locations
This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...
Phase 1, Phase 2
Washington, District of Columbia, United States and 1 other location
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Baltimore, Maryland, United States and 9 other locations
This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...
Phase 2
Baltimore, Maryland, United States and 4 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Baltimore, Maryland, United States and 9 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Bethesda, Maryland, United States and 35 other locations
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Washington, District of Columbia, United States and 8 other locations
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...
Phase 2
Washington, District of Columbia, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal